Skip to main content

UW seeks 2,000 people for Phase III clinical trial of potential COVID-19 vaccine

A crucial Phase III clinical trial of a vaccine against COVID-19 begins this week at the University of Wisconsin-Madison School of Medicine and Public Health and its teaching hospital UW Health.